Loomis Sayles & Co. L P Increases Stock Position in Option Care Health, Inc. $OPCH

Loomis Sayles & Co. L P boosted its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 3.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 969,296 shares of the company’s stock after acquiring an additional 30,829 shares during the period. Loomis Sayles & Co. L P owned 0.60% of Option Care Health worth $31,483,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Strs Ohio bought a new position in shares of Option Care Health during the first quarter worth $636,000. Prospector Partners LLC lifted its stake in Option Care Health by 22.9% in the 1st quarter. Prospector Partners LLC now owns 111,200 shares of the company’s stock worth $3,886,000 after purchasing an additional 20,700 shares in the last quarter. Andina Capital Management LLC purchased a new stake in Option Care Health in the 1st quarter worth $513,000. Advantage Alpha Capital Partners LP boosted its holdings in shares of Option Care Health by 78.7% during the 1st quarter. Advantage Alpha Capital Partners LP now owns 214,619 shares of the company’s stock valued at $7,501,000 after purchasing an additional 94,528 shares during the last quarter. Finally, Fort Washington Investment Advisors Inc. OH grew its position in shares of Option Care Health by 11.8% during the second quarter. Fort Washington Investment Advisors Inc. OH now owns 883,404 shares of the company’s stock valued at $28,693,000 after purchasing an additional 92,984 shares in the last quarter. Institutional investors own 98.05% of the company’s stock.

Insider Buying and Selling at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. bought 38,000 shares of Option Care Health stock in a transaction dated Monday, November 3rd. The shares were acquired at an average price of $25.98 per share, with a total value of $987,240.00. Following the completion of the purchase, the director owned 413,390 shares in the company, valued at $10,739,872.20. The trade was a 10.12% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Norman L. Wright purchased 3,411 shares of the company’s stock in a transaction that occurred on Tuesday, September 9th. The shares were purchased at an average cost of $29.31 per share, with a total value of $99,976.41. Following the completion of the purchase, the director owned 15,501 shares in the company, valued at $454,334.31. This trade represents a 28.21% increase in their position. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 0.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently commented on OPCH. Cowen began coverage on Option Care Health in a research report on Thursday, October 2nd. They issued a “hold” rating on the stock. JMP Securities set a $36.00 price objective on Option Care Health in a report on Friday, October 31st. Barrington Research reiterated an “outperform” rating and set a $38.00 target price on shares of Option Care Health in a research report on Friday, October 31st. Morgan Stanley started coverage on shares of Option Care Health in a report on Friday, October 17th. They issued an “overweight” rating and a $35.00 target price for the company. Finally, Wall Street Zen downgraded shares of Option Care Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Nine investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, Option Care Health currently has a consensus rating of “Moderate Buy” and an average target price of $35.67.

Option Care Health Stock Performance

NASDAQ:OPCH opened at $31.10 on Friday. The firm has a market capitalization of $4.94 billion, a PE ratio of 24.88, a PEG ratio of 1.74 and a beta of 0.88. The stock’s fifty day moving average is $27.98 and its 200 day moving average is $29.40. Option Care Health, Inc. has a fifty-two week low of $22.29 and a fifty-two week high of $35.53. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.